Extended Interview with Thompson Brothers on Lacrosse, the Medicine Game, and their Sticks – Video

Posted on by


Extended Interview with Thompson Brothers on Lacrosse, the Medicine Game, and their Sticks
We enjoyed talking to these guys so much we thought you should see the full interview. Extended Interview with Thompson Brothers on Lacrosse, the Medicine Ga...

By: Stylin Strings

View original post here:

Extended Interview with Thompson Brothers on Lacrosse, the Medicine Game, and their Sticks - Video

BUSM identifies barriers to implementing complimentary medicine curricula into residency

Posted on by

Public release date: 9-Oct-2013 [ | E-mail | Share ]

Contact: Gina DiGravio gina.digravio@bmc.org 617-638-8480 Boston University Medical Center

(Boston) - Investigators at Boston University School of Medicine (BUSM) have identified that lack of time and a paucity of trained faculty are perceived as the most significant barriers to incorporating complementary and alternative medicine (CAM) and integrative medicine (IM) training into family medicine residency curricula and training programs.

The study results, which are published online in Explore: The Journal of Science and Healing, were collected using data from an online survey completed by 212 national residency program directors. The study was led by Paula Gardiner, MD, MPH, assistant professor of family medicine at BUSM and assistant director of integrative medicine at Boston Medical Center, and colleagues from the department of Family Medicine.

"This is a part of medicine that has significant impact on patient care," said Gardiner. "We need to minimize barriers to implementing CAM/IM curricula in order to address these competencies and promote a larger focus on patient centered care."

According to the current study a majority of family medicine residency program directors felt that CAM and IM were an important part of resident training and, of those, a majority was aware of these recommended competencies. However, a majority of directors also did not have specific learning goals around CAM and IM in their residency programs. Of those directors aware of the competencies, a minority had an adequate evaluation of CAM or IM in their program.

The survey respondents identified "strong" CAM/IM programs as those that incorporated at least one of the following modes of exposing residents to CAM or IM: didactics, clinical rotations or electives. "Weak" programs incorporated none of these modalities. Didactics were the most commonly employed techniques of the strong programs. There were significant differences between the strong and weak programs in perceived access to experts in CAM or IM and faculty training in these modalities.

The study was conducted via an online survey and consisted of six questions on CAM and IM with a focus on awareness, competencies, attitudes toward curricula, barriers to implementation and management techniques.

Given the use of CAM and IM modalities by patients and practicing physicians future directions should include raising awareness around the proposed competencies and identifying solutions to minimize the barriers to incorporating these competencies in residency training programs.

###

See more here:

BUSM identifies barriers to implementing complimentary medicine curricula into residency

Barriers to implementing complimentary medicine into MD residency

Posted on by

Oct. 9, 2013 Investigators at Boston University School of Medicine (BUSM) have identified that lack of time and a paucity of trained faculty are perceived as the most significant barriers to incorporating complementary and alternative medicine (CAM) and integrative medicine (IM) training into family medicine residency curricula and training programs.

The study results, which are published online in Explore: The Journal of Science and Healing, were collected using data from an online survey completed by 212 national residency program directors. The study was led by Paula Gardiner, MD, MPH, assistant professor of family medicine at BUSM and assistant director of integrative medicine at Boston Medical Center, and colleagues from the department of Family Medicine.

"This is a part of medicine that has significant impact on patient care," said Gardiner. "We need to minimize barriers to implementing CAM/IM curricula in order to address these competencies and promote a larger focus on patient centered care."

According to the current study a majority of family medicine residency program directors felt that CAM and IM were an important part of resident training and, of those, a majority was aware of these recommended competencies. However, a majority of directors also did not have specific learning goals around CAM and IM in their residency programs. Of those directors aware of the competencies, a minority had an adequate evaluation of CAM or IM in their program.

The survey respondents identified "strong" CAM/IM programs as those that incorporated at least one of the following modes of exposing residents to CAM or IM: didactics, clinical rotations or electives. "Weak" programs incorporated none of these modalities. Didactics were the most commonly employed techniques of the strong programs. There were significant differences between the strong and weak programs in perceived access to experts in CAM or IM and faculty training in these modalities.

The study was conducted via an online survey and consisted of six questions on CAM and IM with a focus on awareness, competencies, attitudes toward curricula, barriers to implementation and management techniques.

Given the use of CAM and IM modalities by patients and practicing physicians future directions should include raising awareness around the proposed competencies and identifying solutions to minimize the barriers to incorporating these competencies in residency training programs.

Go here to see the original:

Barriers to implementing complimentary medicine into MD residency

Penn Medicine Names First Leader of Precision Medicine to Speed Delivery of Tailored Treatments to Patients

Posted on by

Newswise PHILADELPHIA D. Gary Gilliland, MD, PhD, has been named the inaugural Vice Dean and Vice President for Precision Medicine, a newly created role to position Penn Medicine as the nations top leader in the delivery of individualized medicine.

Dr. Gilliland, a cancer genetics expert and pioneer in the development of targeted therapies, will synthesize Penn Medicines research and clinical care initiatives across all disciplines to create a national model for the delivery of precise, personalized medicine to patients with diseases of all kinds. He will work with the institutions top leaders in cancer, heart and vascular medicine, neurosciences, genetics, pathology, and many other specialties.

We are proud to be among the first institutions in the country to create a position to oversee the tremendous opportunities and challenges that face us as our physicians and scientists work to hone the promise of the burgeoning and exciting field of precision medicine, says J. Larry Jameson, MD, PhD, Executive Vice President of the University of Pennsylvania for the Health System and Dean of the Perelman School of Medicine. Dr. Gillilands experience as a leader in both academic medicine and the pharmaceutical industry will help Penn Medicine forge a roadmap for the most effective and efficient ways to conduct research and deliver care in this new field.

The establishment of the new role builds on such existing Penn Medicine efforts as the Institute for Translational Medicine and Therapeutics and the newly launched Center for Personalized Diagnostics.

Penn Medicine already has a strong base in this new field, and Dr. Gillilands background and accomplishments will provide experienced leadership to take us to the next level of excellence, says Ralph W. Muller, Chief Executive Officer of the University of Pennsylvania Health System. No matter what its called precision medicine, personalized medicine, or individualized medicine this extremely promising approach will better equip physicians to match the most effective treatment to each patients specific disease.

Gilliland joins Penn Medicine from Merck, where he was recruited in 2009 as Senior Vice President of Merck Research Laboratories and Oncology Franchise Head, following a long career at Harvard Medical School. At Merck, he was responsible for end-to-end research and development of its Global Oncology Programs. He oversaw first-in-human studies, proof-of-concept trials, and Phase II/III registration trials, and managed all preclinical and clinical oncology licensing activities.

Prior to joining Merck, Gilliland was a member of the faculty at Harvard Medical School for nearly 20 years, where he served as Professor of Medicine and a Professor of Stem Cell and Regenerative Biology. He was also an Investigator of the Howard Hughes Medical Institute, Director of the Leukemia Program at the Dana-Farber/Harvard Cancer Center, and Director of the Cancer Stem Cell Program of the Harvard Stem Cell Institute. He saw patients at numerous top Boston hospitals, serving as an attending physician in the Bone Marrow Transplant Service of Childrens Hospital; attending physician in medical oncology at Dana-Farber Cancer Institute; and senior attending physician at Brigham and Womens Hospital.

As an investigator studying hematologic malignancies, Gilliland made seminal discoveries that have contributed to the understanding of the genetic basis of leukemias and other cancers that affect the blood and bone marrow. He has worked to help apply these findings into the development of new investigational cancer treatments, including molecularly targeted therapies, and has advanced this research into all phases of clinical development.

His work has earned him numerous honors, including the William Dameshek Prize from the American Society of Hematology, the Emil J. Freireich Award from the MD Anderson Cancer Center, and the Stanley J. Korsmeyer Award from the American Society for Clinical Investigation. He is an elected member of the America Society for Clinical Investigation and the American Association of Physicians.

He received his Ph.D. in Microbiology from the University of California, Los Angeles, and his M.D. from the University of California, San Francisco. He completed his internship and residency, including serving as Chief Medical Resident, at Brigham and Women's Hospital, Harvard Medical School. He completed his Hematology and Medical Oncology training at the Brigham and Womens Hospital and the Dana-Farber Cancer Institute, respectively.

View original post here:

Penn Medicine Names First Leader of Precision Medicine to Speed Delivery of Tailored Treatments to Patients

UT Health Science Center medical school off probation

Posted on by

SAN ANTONIO The University of Texas Health Science Center announced two doses of good news this week the return to full accreditation of its medical school after two years on probation and the $22.7 million renewal of a National Institutes of Health grant for another five years.

Probation didn't mean loss of accreditation. Still, second-year medical student Monica Ruiz, 23, called the announcement a big win for us and said students began clapping when they found out via email around lunchtime Monday.

Ruiz, of Rio Grande City, decided to attend medical school at the health science center after the Oct. 2011 vote by the Liaison Committee on Medical Education to place the school on probation for not complying with 10 aspects of its accreditation standards, largely related to the school's curriculum, faculty supervision and lack of centralized clinical activities.

The school's staff had worked hard for two years to remedy those problems, Dr. Francisco Gonzlez-Scarano, dean of the medical school, said Tuesday. He'd received word last week that the LCME had voted to lift the probationary status.

The committee accredits programs that lead to an M.D. in the United States and Canada. American schools need it to maintain eligibility for some federal grants and programs and for their graduates to be licensed by state boards and be eligible for residencies accredited by the Accreditation Council for Graduate Medical Education, according to the LCME website.

Gonzlez said the school redesigned its curriculum from an outdated lecture-driven version to one that emphasizes individual instruction intended to prepare students for lifelong learning as doctors. The school also moved supervision of faculty in seven basic science departments from the dean of the graduate school of biomedical sciences to the dean of the medical school, he said.

Clinical activities have also been centralized in a way that can be tracked by computer, he said.

Ruiz and fellow second-year medical student Kristopher Koch, 30, said they benefit from greater scheduling flexibility that enables them to do things like volunteering in clinics, shadowing a mentor or participating in student organizations.

I just don't know that I would have had the energy if I'd been in class from 8 a.m. to 5 p.m., Ruiz said.

Gonzlez said applications to the medical school increased during the probationary period, following a national trend, but said in instances where students weighed two schools, it could have been a factor in their final decisions.

Originally posted here:

UT Health Science Center medical school off probation

Phillips Chevrolet Customer Review – 2008 Jeep Liberty – Used Car Dealer Sales Chicago – Video

Posted on by


Phillips Chevrolet Customer Review - 2008 Jeep Liberty - Used Car Dealer Sales Chicago
http://www.phillipschevy.com/used - At Phillips Chevrolet in Frankfort, Illinois, you #39;ll be sure to find a great deal on any car! Scott and Mary are here wit...

By: PhillipsChevy

See the original post here:

Phillips Chevrolet Customer Review - 2008 Jeep Liberty - Used Car Dealer Sales Chicago - Video